CAR-T Cell Product Development Guidance Covers Previous Recipients, ‘Bridging Therapy’

 
• By Sue Sutter
  
Bridge
Sponsors may need to consider 'bridging therapy' in their CAR-T study protocols. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Advanced Technologies